The Utility of Time Segmental Withdrawal During Screening Colonoscopy for Increasing Adenoma Detection Rate.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02538406|
Recruitment Status : Suspended (Requested to pause recruitment by local IRB while undergoing review.)
First Posted : September 2, 2015
Last Update Posted : January 14, 2020
|Condition or disease||Intervention/treatment|
|Adenomatous Polyp of Colon||Other: Segmental withdrawal|
|Study Type :||Observational|
|Estimated Enrollment :||400 participants|
|Official Title:||The Utility of Time Segmental Withdrawal During Screening Colonoscopy for Increasing Adenoma Detection Rate. A Randomized Controlled Clinical Trial.|
|Study Start Date :||August 2015|
|Estimated Primary Completion Date :||June 2020|
|Estimated Study Completion Date :||June 2020|
non segmental withdrawal
A standard of care colonoscopy will be done on the patient without extra time on the right side of the colon.
A standard of care colonoscopy will be done on the patient , however the time spent in the right side of the colon will be more than half of the normal colonoscopy procedure (i.e. more than 3 minutes)
Other: Segmental withdrawal
Interventional group will have at least 3 minutes dedicated to the right side of the colon during segmental withdrawal.
- Increase in detection rate of adenomas in the right side of the colon [ Time Frame: 30 minutes ]To determine if timed segmental withdrawal protocol can increase the adenoma detection rate in the right side of the colon compared to non segmental withdrawal.
- Sessile Serrated lesion detection rate [ Time Frame: 30 minutes ]Compare sessile serrated lesion detection rate between patients undergoing a screening colonoscopy with segmental withdrawal protocol and non-segmental withdrawal protocol.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02538406
|United States, Texas|
|Baylor College of Medicine|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Mohamed O. Othman, MD||Baylor College of Medicine|